FDA Inspection 1152172 — Shandong Xinhua Pharmaceuticals (USA) Inc.
The FDA completed an inspection of Shandong Xinhua Pharmaceuticals (USA) Inc. on June 2, 2021 in South El Monte, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Food/Cosmetics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 2, 2021
- Fiscal Year
- 2021
- Product Type
- Food/Cosmetics
- Project Area
- Foodborne Biological Hazards
- Location
- South El Monte, CA (United States)